Burgeoning Competition in SPR Market

ABI 8500 Affinity Chip AnalyzerCourtesy of Applied BiosystemsFor labs equipped to measure surface plasmon resonance (SPR), determining how biomolecules interact with each other is simple. Load a glass slide into the benchtop instrument, give it some tubes, click the mouse a few times, and voila! – out come affinity measurements, on-rates, off-rates, and dissociation constants, all in real time."We can absolutely determine affinity, concentration, and all other things," says Stefan Lofas, v

Written byJosh Roberts
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Courtesy of Applied Biosystems

For labs equipped to measure surface plasmon resonance (SPR), determining how biomolecules interact with each other is simple. Load a glass slide into the benchtop instrument, give it some tubes, click the mouse a few times, and voila! – out come affinity measurements, on-rates, off-rates, and dissociation constants, all in real time.

"We can absolutely determine affinity, concentration, and all other things," says Stefan Lofas, vice president and CSO of Uppsala, Sweden-based Biacore http://www.biacore.com, a leading manufacturer of SPR instruments. "But I think the kinetic aspect is the thing that customers are recognizing our type of system for." Receptor-ligand interactions, enzyme-substrate combinations, and drug-target binding are among the subjects of more than 3,000 peer-reviewed publications to Biacore's credit since introducing SPR to the biomedical community in 1990.

A few competitors have come and gone, Lofas points out, and a few smaller players worldwide are still on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies